Bulk Manufacturer of Controlled Substances Application: IsoSciences, LLC, 3197-3198 [2021-00647]

Download as PDF 3197 Federal Register / Vol. 86, No. 9 / Thursday, January 14, 2021 / Notices including the validity of the methodology and assumptions used; —Evaluate whether and if so how the quality, utility, and clarity of the information to be collected can be enhanced; and —Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. khammond on DSKJM1Z7X2PROD with NOTICES Overview of This Information Collection 1. Type of Information Collection (check justification or form 83): Extension with change of a currently approved collection. 2. The Title of the Form/Collection: Records and Supporting Data: Importation, Receipt, Storage, and Disposition by Explosives Importers, Manufacturers, Dealers, and Users Licensed Under Title 18 U.S.C. Chapter 40 Explosives. 3. The agency form number, if any, and the applicable component of the Department sponsoring the collection: Form number (if applicable): None. Component: Bureau of Alcohol, Tobacco, Firearms and Explosives, U.S. Department of Justice. 4. Affected public who will be asked or required to respond, as well as a brief abstract: Primary: Business or other for-profit. Other (if applicable): None. Abstract: This information collection requires the maintenance of records showing daily activities in the importation, manufacture, receipt, storage, and disposition of all explosive materials covered under 18 U.S.C. Chapter 40 Explosives. These records must also show where and to whom explosive materials are sent, thereby ensuring that any diversions will be readily apparent, and that ATF will be immediately notified if these materials are lost or stolen. 5. An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: An estimated 9,411 respondents will prepare records for this information collection annually, and it will take each respondent approximately 12.6 hours to prepare the required records. 6. An estimate of the total public burden (in hours) associated with the collection: The estimated annual public burden associated with this collection is 592,893 hours, which is equal to 47,055 VerDate Sep<11>2014 03:30 Jan 14, 2021 Jkt 253001 (# of annual responses) * 12.6 (# of hours per response). 7. An Explanation of the Change in Estimates: The adjustments associated with this collection include a decrease in the number of respondents, responses and total burden hours by 516, 2,580, and 32,508 hours respectively, since the last IC renewal in 2017. If additional information is required contact: Melody Braswell, Department Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Two Constitution Square, 145 N Street NE, 3E.405A, Washington, DC 20530. following basic class of controlled substance: Controlled substance Ecgonine ....................... Drug code 9180 Schedule II The company plans to produce the listed controlled substance in bulk to be used in the manufacture of DEA exempt products. No other activities for these drug codes are authorized for this registration. William T. McDermott, Assistant Administrator. [FR Doc. 2021–00648 Filed 1–13–21; 8:45 am] Dated: January 11, 2021. Melody Braswell, Department Clearance Officer for PRA, U.S. Department of Justice. BILLING CODE P [FR Doc. 2021–00743 Filed 1–13–21; 8:45 am] Drug Enforcement Administration BILLING CODE 4410–02–P [Docket No. DEA–766] DEPARTMENT OF JUSTICE Drug Enforcement Administration Bulk Manufacturer of Controlled Substances Application: Siemens Healthcare Diagnostics Inc. Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: Siemens Healthcare Diagnostics Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before March 15, 2021. Such persons may also file a written request for a hearing on the application on or before March 15, 2021. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUMMARY: In accordance with 21 CFR 1301.33(a), this is notice that on December 11, 2020, Siemens Healthcare Diagnostics Inc., 100 GBC Drive, Mailstop 514, Newark, Delaware 19702–2461, applied to be registered as a bulk manufacturer of the SUPPLEMENTARY INFORMATION: Frm 00089 Fmt 4703 Bulk Manufacturer of Controlled Substances Application: IsoSciences, LLC Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: [Docket No. DEA–768] PO 00000 DEPARTMENT OF JUSTICE Sfmt 4703 IsoSciences, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTAL INFORMATION listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before March 15, 2021. Such persons may also file a written request for a hearing on the application on or before March 15, 2021. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this is notice that on November 11, 2020, IsoSciences, LLC, 340 Mathers Road, Ambler, Pennsylvania 19002–3420, applied to be registered as an bulk manufacturer of the following basic class(es) of controlled substance(s): SUMMARY: Controlled substance Cathinone ................................ Methcathinone ........................ Lysergic acid diethylamide ..... Marihuana ............................... E:\FR\FM\14JAN1.SGM 14JAN1 Drug code 1235 1237 7315 7360 Schedule I I I I 3198 Federal Register / Vol. 86, No. 9 / Thursday, January 14, 2021 / Notices khammond on DSKJM1Z7X2PROD with NOTICES Controlled substance Tetrahydrocannabinols ........... 3,4-Methylene dioxyamphetamine. 3,4-Methylenedioxy-Nethylamphetamine. 3,4-Methylene dioxymethamphetamine. 5-Methoxy-N–Ndimethyltryptamine. Alpha-methyltryptamine .......... Bufotenine ............................... Diethyltryptamine .................... Dimethyltryptamine ................. Psilocybin ................................ Psilocyn ................................... 5-Methoxy-N,Ndiisopropyltryptamine. Dihydromorphine ..................... Heroin ..................................... Nicocodeine ............................ Nicomorphine .......................... Normorphine ........................... Thebacon ................................ Normethadone ........................ Acryl fentanyl (N-(1phenethylpiperidin-4-yl)-Nphenylacrylamide). Para-Fluorofentanyl ................ 3-Methylfentanyl ...................... Alpha-methylfentanyl .............. Acetyl-alpha-methylfentanyl .... N-(2-fluorophenyl)-N-(1phenethylpiperidin-4yl)propionamide. Acetyl Fentanyl (N-(1phenethylpiperidin-4-yl)-Nphenylacetamide). Butyryl Fentanyl ...................... 4-Fluoroisobutyryl fentanyl (N(4-fluorophenyl)-N-(1phenethylpiperidin-4yl)isobutyramide). 2-methoxy-N-(1phenethylpiperidin-4-yl)-Nphenylacetamide. Beta-hydroxyfentanyl .............. Beta-hydroxy-3-methylfentanyl Alpha-methylthiofentanyl ......... 3-Methylthiofentanyl ................ Furanyl fentanyl (N-(1phenethylpiperidin-4-yl)-Nphenylfuran-2-carboxamide). Thiofentanyl ............................ Beta-hydroxythiofentanyl ........ N-(1-phenethylpiperidin-4-yl)N-phenyltetrahydrofuran-2carboxamide. Amphetamine .......................... Methamphetamine .................. Codeine ................................... Dihydrocodeine ....................... Oxycodone .............................. Hydromorphone ...................... Hydrocodone ........................... Isomethadone ......................... Methadone .............................. Methadone intermediate ......... Morphine ................................. Thebaine ................................. Levo-alphacetylmethadol ........ Oxymorphone ......................... Thiafentanil ............................. Alfentanil ................................. Sufentanil ................................ Carfentanil ............................... Fentanyl .................................. Drug code Schedule 7370 7400 I I 7404 I 7405 I William T. McDermott, Assistant Administrator. 7431 I [FR Doc. 2021–00647 Filed 1–13–21; 8:45 am] 7432 7433 7434 7435 7437 7438 7439 I I I I I I I 9145 9200 9309 9312 9313 9315 9635 9811 I I I I I I I I 9812 9813 9814 9815 9816 I I I I I 9821 I 9822 9824 I I 9825 I 9830 9831 9832 9833 9834 I I I I I 9835 9836 9843 I I I 1100 1105 9050 9120 9143 9150 9193 9226 9250 9254 9300 9333 9648 9652 9729 9737 9740 9743 9801 II II II II II II II II II II II II II II II II II II II BILLING CODE P The company plans to manufacture bulk controlled substances for use in analytical testing. In reference to drug codes 7360 (Marihuana) and 7370 VerDate Sep<11>2014 (Tetrahydrocannabinols), the company plans to bulk manufacture these drugs as synthetics. No other activities for these drug codes are authorized for this registration. 23:48 Jan 13, 2021 Jkt 253001 DEPARTMENT OF JUSTICE [OMB Number 1121–0269] Agency Information Collection Activities: Proposed Collection; Comments Requested; Reinstatement, With Change, of a Previously Approved Collection for Which Approval Has Expired: 2020 Census of Publicly Funded Forensic Crime Laboratories (CPFFCL) Bureau of Justice Statistics, Department of Justice. ACTION: 60-day notice. AGENCY: The Department of Justice (DOJ), Office of Justice Programs, Bureau of Justice Statistics, will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. DATES: Comments are encouraged and will be accepted for 60 days until March 15, 2021. FOR FURTHER INFORMATION CONTACT: If you have additional comments especially on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact Connor Brooks, Statistician, Law Enforcement Statistics Unit, Bureau of Justice Statistics, 810 Seventh Street NW, Washington, DC 20531 (email: Connor.Brooks@usdoj.gov; phone: 202– 514–8633). SUPPLEMENTARY INFORMATION: Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the Bureau of Justice Statistics, including whether the information will have practical utility; —Evaluate the accuracy of the agency’s estimate of the burden of the SUMMARY: PO 00000 Frm 00090 Fmt 4703 Sfmt 4703 proposed collection of information, including the validity of the methodology and assumptions used; —Evaluate whether and if so how the quality, utility, and clarity of the information to be collected can be enhanced; and —Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Overview of This Information Collection (1) Type of Information Collection: Reinstatement of the Census of Publicly Funded Forensic Crime Laboratories, with changes, of a previously approved collection for which approval has expired. (2) The Title of the Form/Collection: 2020 Census of Publicly Funded Forensic Crime Laboratories. (3) The agency form number, if any, and the applicable component of the Department sponsoring the collection: The form number is CFCL–20. The applicable component within the Department of Justice is the Bureau of Justice Statistics, Office of Justice Programs. (4) Affected public who will be asked or required to respond, as well as a brief abstract: This information collection is a census of federal, state, and local publicly funded forensic crime laboratories that analyze criminal evidence. This data collection follows the 2014 study and will collect information on personnel, budgets, workloads, policies, and procedures of crime laboratories. BJS plans to field the 2020 CPFFCL from May to October 2021. The census form was assessed by practitioners and subject matter experts to update it from the 2014 form and ensure its relevance to forensic crime laboratories as well as reduce respondent burden. The form was then cognitively tested with 23 forensic crime laboratories of different sizes, regions, and government levels. In addition to collecting detailed data for the 2020 reference year, CPFFCL will also collect summary data for the 2019 reference year. (5) An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: A projected 500 respondents will take an average of 2.5 hours each to complete form, including time to research or find information not readily E:\FR\FM\14JAN1.SGM 14JAN1

Agencies

[Federal Register Volume 86, Number 9 (Thursday, January 14, 2021)]
[Notices]
[Pages 3197-3198]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-00647]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-766]


Bulk Manufacturer of Controlled Substances Application: 
IsoSciences, LLC

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: IsoSciences, LLC has applied to be registered as a bulk 
manufacturer of basic class(es) of controlled substance(s). Refer to 
SUPPLEMENTAL INFORMATION listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before March 15, 2021. 
Such persons may also file a written request for a hearing on the 
application on or before March 15, 2021.

ADDRESSES:  Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on November 11, 2020, IsoSciences, LLC, 340 Mathers 
Road, Ambler, Pennsylvania 19002-3420, applied to be registered as an 
bulk manufacturer of the following basic class(es) of controlled 
substance(s):

------------------------------------------------------------------------
                                          Drug
          Controlled substance            code           Schedule
------------------------------------------------------------------------
Cathinone..............................    1235  I
Methcathinone..........................    1237  I
Lysergic acid diethylamide.............    7315  I
Marihuana..............................    7360  I

[[Page 3198]]

 
Tetrahydrocannabinols..................    7370  I
3,4-Methylenedioxyamphetamine..........    7400  I
3,4-Methylenedioxy-N-ethylamphetamine..    7404  I
3,4-Methylenedioxymethamphetamine......    7405  I
5-Methoxy-N-N-dimethyltryptamine.......    7431  I
Alpha-methyltryptamine.................    7432  I
Bufotenine.............................    7433  I
Diethyltryptamine......................    7434  I
Dimethyltryptamine.....................    7435  I
Psilocybin.............................    7437  I
Psilocyn...............................    7438  I
5-Methoxy-N,N-diisopropyltryptamine....    7439  I
Dihydromorphine........................    9145  I
Heroin.................................    9200  I
Nicocodeine............................    9309  I
Nicomorphine...........................    9312  I
Normorphine............................    9313  I
Thebacon...............................    9315  I
Normethadone...........................    9635  I
Acryl fentanyl (N-(1-phenethylpiperidin-   9811  I
 4-yl)-N-phenylacrylamide).
Para-Fluorofentanyl....................    9812  I
3-Methylfentanyl.......................    9813  I
Alpha-methylfentanyl...................    9814  I
Acetyl-alpha-methylfentanyl............    9815  I
N-(2-fluorophenyl)-N-(1-                   9816  I
 phenethylpiperidin-4-yl)propionamide.
Acetyl Fentanyl (N-(1-                     9821  I
 phenethylpiperidin-4-yl)-N-
 phenylacetamide).
Butyryl Fentanyl.......................    9822  I
4-Fluoroisobutyryl fentanyl (N-(4-         9824  I
 fluorophenyl)-N-(1-phenethylpiperidin-
 4-yl)isobutyramide).
2-methoxy-N-(1-phenethylpiperidin-4-yl)-   9825  I
 N-phenylacetamide.
Beta-hydroxyfentanyl...................    9830  I
Beta-hydroxy-3-methylfentanyl..........    9831  I
Alpha-methylthiofentanyl...............    9832  I
3-Methylthiofentanyl...................    9833  I
Furanyl fentanyl (N-(1-                    9834  I
 phenethylpiperidin-4-yl)-N-phenylfuran-
 2-carboxamide).
Thiofentanyl...........................    9835  I
Beta-hydroxythiofentanyl...............    9836  I
N-(1-phenethylpiperidin-4-yl)-N-           9843  I
 phenyltetrahydrofuran-2-carboxamide.
Amphetamine............................    1100  II
Methamphetamine........................    1105  II
Codeine................................    9050  II
Dihydrocodeine.........................    9120  II
Oxycodone..............................    9143  II
Hydromorphone..........................    9150  II
Hydrocodone............................    9193  II
Isomethadone...........................    9226  II
Methadone..............................    9250  II
Methadone intermediate.................    9254  II
Morphine...............................    9300  II
Thebaine...............................    9333  II
Levo-alphacetylmethadol................    9648  II
Oxymorphone............................    9652  II
Thiafentanil...........................    9729  II
Alfentanil.............................    9737  II
Sufentanil.............................    9740  II
Carfentanil............................    9743  II
Fentanyl...............................    9801  II
------------------------------------------------------------------------

    The company plans to manufacture bulk controlled substances for use 
in analytical testing. In reference to drug codes 7360 (Marihuana) and 
7370 (Tetrahydrocannabinols), the company plans to bulk manufacture 
these drugs as synthetics. No other activities for these drug codes are 
authorized for this registration.

William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-00647 Filed 1-13-21; 8:45 am]
BILLING CODE P